Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 31, 2018 09:00 ET | Source: Amedica Corporation

AMEDICA ANNOUNCES CORPORATE NAME CHANGE TO SINTX TECHNOLOGIES, INC.

SALT LAKE CITY, Oct. 31, 2018 (GLOBE NEWSWIRE) -- Amedica Corporation (NASDAQ: AMDA), a company that develops and commercializes silicon nitride for biomedical applications, announced that it has...
October 03, 2018 09:00 ET | Source: Amedica Corporation

AMEDICA ANNOUNCES CLOSING OF THE SALE OF ITS SPINE BUSINESS TO CTL MEDICAL

SALT LAKE CITY, Oct. 03, 2018 (GLOBE NEWSWIRE) -- Amedica Corporation (NASDAQ: AMDA) today announced that it has completed the previously-announced sale of its spine business to CTL Medical, a...
September 11, 2018 09:00 ET | Source: Amedica Corporation

Amedica Corporation to Host Conference Call to Discuss Recent Sale of Spine Implant Business and Transition to Biomaterials Company

SALT LAKE CITY, Sept. 11, 2018 (GLOBE NEWSWIRE) -- Amedica Corporation (NASDAQ: AMDA), a company that develops and commercializes silicon nitride for biomedical applications, announced today that...
September 10, 2018 09:00 ET | Source: Amedica Corporation

AMEDICA ANNOUNCES FILING OF KEY PATENT APPLICATION RELATING TO THE ANTI-VIRAL EFFECT OF ITS SILICON NITRIDE

SALT LAKE CITY, Sept. 10, 2018 (GLOBE NEWSWIRE) -- Amedica Corporation (NASDAQ: AMDA), a company that develops and commercializes silicon nitride for biomedical applications, today announced the...
September 06, 2018 09:00 ET | Source: Amedica Corporation

AMEDICA ANNOUNCES AGREEMENT TO SELL SPINE BUSINESS TO CTL MEDICAL

SALT LAKE CITY, Sept. 06, 2018 (GLOBE NEWSWIRE) -- Amedica Corporation (NASDAQ: AMDA) today announced that it has entered into an asset purchase agreement with CTL Medical, a Dallas, TX-based...
August 21, 2018 09:00 ET | Source: Amedica Corporation

Amedica Announces Successful Completion of First Valeo® C+CSC with Lumen Interbody Fusion Surgery

SALT LAKE CITY, Aug. 21, 2018 (GLOBE NEWSWIRE) -- Amedica Corporation (NASDAQ: AMDA), an innovative biomaterial company that develops and commercializes silicon nitride for biomedical applications,...
May 14, 2018 16:26 ET | Source: Amedica Corporation

Amedica Corporation Announces Closing of $15,000,000 Public Offering of Units Consisting of Convertible Preferred Stock and Warrants

SALT LAKE CITY, May 14, 2018 (GLOBE NEWSWIRE) -- Amedica Corporation (NASDAQ: AMDA) an innovative biomaterial company that develops and commercializes silicon nitride for biomedical applications,...
May 10, 2018 09:20 ET | Source: Amedica Corporation

Amedica Corporation Announces Pricing of $15,000,000 Public Offering of Units Consisting of Convertible Preferred Stock and Warrants

SALT LAKE CITY, May 10, 2018 (GLOBE NEWSWIRE) -- Amedica Corporation (NASDAQ: AMDA) an innovative biomaterial company that develops and commercializes silicon nitride for biomedical applications,...
May 08, 2018 09:30 ET | Source: Amedica Corporation

Amedica Corporation Provides Update on its Clinical Studies

SALT LAKE CITY, May 08, 2018 (GLOBE NEWSWIRE) -- Amedica Corporation (NASDAQ: AMDA), an innovative biomaterial company that develops and commercializes silicon nitride for biomedical applications,...
March 30, 2018 09:00 ET | Source: Amedica Corporation

Amedica Announces Patent Grant for Silicon Nitride and Other Ceramic Materials

SALT LAKE CITY, March 30, 2018 (GLOBE NEWSWIRE) -- Amedica Corporation (Nasdaq:AMDA), an innovative biomaterial company which develops and manufactures silicon nitride as a platform for biomedical...

Next Page keyboard_arrow_right